Health Care: Drugs

Albany Molecular Research Inc (AMRI: NASDAQ)

$15.85 0.35 | 2.26%
11/26/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 246.58M 226.69M 207.64M 198.07M
Cost of Sales 155.52M 150.73M 150.32M 135.21M
Gross Operating Profit 91.05M 75.95M 57.33M 62.85M
Selling, General, and Administrative Expenses 45.02M 44.05M 44.76M 55.68M
Research & Development 414.00K 906.00K 7.94M 11.09M
Operating Income before D & A (EBITDA) 45.62M 31.00M 4.64M -3.91M
Depreciation & Amortization 16.40M 17.33M 18.16M 17.46M
Interest Income 11.00K 9.00K 131.00K 452.00K
Other Income - Net 772.00K -130.00K 77.00K -962.00K
Special Income / Charges -1.86M -8.33M -21.34M -47.69M
Total Income Before Interest Expenses (EBIT) 20.96M 582.00K -35.92M -72.67M
Interest Expense 1.26M 463.00K 714.00K 175.00K
Pre-Tax Income 19.70M 119.00K -36.64M -72.84M
Income Taxes 7.02M 3.90M -4.34M -9.97M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 12.68M -3.78M -32.30M -62.87M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 12.68M -3.78M -32.30M -62.87M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 12.68M -3.78M -32.30M -62.87M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
21.72M 9.19M -9.68M -12.09M
Preferred Dividends
Net Income Available To Common 12.68M -3.78M -32.30M -62.87M
Basic EPS from Continuing Ops. 0.41 -0.12 -1.08 -2.05
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.41 -0.12 -1.08 -2.05
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.41 -0.12 -1.08 -2.05
Basic Normalized Net Income/Share 0.70 0.30 -0.32 -0.39
EPS fr Continuing Ops. 0.41 -0.12 -1.08 -2.05
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.41 -0.12 -1.08 -2.05
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.01 0.00 0.00 0.00
EPS, Total 0.40 -0.12 -1.08 -2.05
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.70 0.30 -0.32 -0.39
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AMRI

Latest AMRI Headlines from TheStreet

More Financial News for AMRI

Press Releases for AMRI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter